Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Axitinib in progressive, recurrent/metastatic adenoid cystic carcinoma
NCT01558661Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Mar 2012
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of axitinib in adenoid cystic carcinoma (ACC), sponsored by Memorial Sloan Kettering Cancer Center. Started Mar 2012; status: completed.
02
Drugs
axitinib
03
Conditions
adenoid cystic carcinoma (ACC)
Beyond the preview
Go deeper on NCT01558661.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01558661.